Optimizing weight control in diabetes: antidiabetic drug selection
S Kalra1, B Kalra1, AG Unnikrishnan2, N Agrawal3, S Kumar41Bharti Hospital, Karnal; 2Amrita Institute of Medical Science, Kochi; 3Medical College, Gwalior; 4Excel Life Sciences, Noida, IndiaDate of preparation: 18th August 2010Conflict of interest: SK has received speaker fees from Novo Nordisk, san...
Enregistré dans:
Auteurs principaux: | S Kalra, B Kalra, AG Unnikrishnan, et al |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/780c84b46b5e4852bc66635152f4d5b5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Optimizing weight control in diabetes: antidiabetic drug selection
par: Kalra S
Publié: (2010) -
Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice
par: Talba T, et autres
Publié: (2011) -
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
par: Kapoor S
Publié: (2012) -
Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
par: Bradley Curtis, et autres
Publié: (2008) -
Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
par: Kalra S, et autres
Publié: (2021)